Lakeside Holding (LSH) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
30 Nov, 2025Use of proceeds and capital allocation
Estimated total expenses for issuance and distribution are $1,404,833, including legal, accounting, and listing fees.
Risk factors and disclosures
Indemnification for directors and officers is provided under Nevada law and company bylaws, with certain limitations for actions not in good faith or against public policy.
Insurance may be maintained for directors, officers, employees, or agents against liabilities incurred in their roles.
SEC may consider some indemnification provisions unenforceable as contrary to public policy.
Management team and governance
Henry Liu serves as Chairman and Chief Executive Officer.
Shuai Li is President, Chief Operating Officer, and Principal Financial and Accounting Officer.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Lakeside Holding
- Quarterly revenue surged 95% with new pharma sales, but net loss and credit risk remain concerns.LSH
H1 202619 Feb 2026 - Board seeks approval for director elections, capital structure changes, and a key subsidiary sale.LSH
Proxy Filing30 Jan 2026 - Shareholders are asked to approve director elections, capital structure changes, and a key subsidiary sale.LSH
Proxy Filing23 Jan 2026 - Proxy seeks approval for director elections, capital structure changes, and subsidiary sale.LSH
Proxy Filing12 Jan 2026 - Shareholders to vote on major capital, governance, and digital asset strategy changes.LSH
Proxy Filing2 Dec 2025 - Shareholders will elect five directors, with strong board independence and oversight.LSH
Proxy Filing2 Dec 2025 - IPO offers 1,250,000 shares plus over-allotment, led by Benchmark and Axiom, Nasdaq listing planned.LSH
Registration Filing30 Nov 2025 - Offering up to 7.97M shares via convertible notes and warrants, with strong Asia-U.S. logistics focus.LSH
Registration Filing29 Nov 2025 - Registering 7.97M shares for resale, the company faces growth, risk, and compliance challenges.LSH
Registration Filing29 Nov 2025